Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Phase 4: Study of Ketamine Inhibition of Interleukin 6 in Hepatic Resections Requiring Temporary Porto-arterial Occlusion

To see complete record on, please visit this link

Id: NCT00978757

Organisation Name: Hospital Italiano de Buenos Aires

Overal Status: Completed

Start Date: June 2001

Last Update: January 15, 2019

Lead Sponsor: Hospital Italiano de Buenos Aires

Brief Summary: The purpose of this study is to determine whether ketamine is effective to inhibit interleukin 6 synthesis in hepatic resections requiring temporary porto-arterial occlusion.

  • Hepatectomy

Total execution time in seconds: 0.21820902824402